AquaBounty Technologies, Inc. (NASDAQ:AQB) Shares Purchased by Epiq Partners LLC

Epiq Partners LLC boosted its stake in AquaBounty Technologies, Inc. (NASDAQ:AQB) by 423.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 89,000 shares of the company’s stock after purchasing an additional 72,000 shares during the period. Epiq Partners LLC owned about 2.30% of AquaBounty Technologies worth $56,000 at the end of the most recent quarter.

AquaBounty Technologies Stock Down 11.9 %

Shares of AQB opened at $0.82 on Tuesday. The company’s 50-day simple moving average is $0.80 and its 200-day simple moving average is $1.08. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.98 and a current ratio of 3.02. AquaBounty Technologies, Inc. has a 1 year low of $0.47 and a 1 year high of $2.79. The stock has a market capitalization of $3.16 million, a PE ratio of -0.04 and a beta of 1.17.

AquaBounty Technologies (NASDAQ:AQB) last released its earnings results on Tuesday, November 5th. The company reported ($0.88) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.88). The company had revenue of $0.05 million for the quarter, compared to analyst estimates of $0.10 million. AquaBounty Technologies had a negative net margin of 5,842.69% and a negative return on equity of 18.20%. During the same period in the prior year, the business earned ($1.60) EPS.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.